These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10695015)

  • 1. [Mechanisms for resistance to anticancer agents and the reversal of the resistance].
    Akiyama S; Chen ZS; Kitazono M; Sumizawa T; Furukawa T; Aikou T
    Hum Cell; 1999 Sep; 12(3):95-102. PubMed ID: 10695015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
    Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S
    Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
    Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
    Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
    Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
    J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
    Borst P; Kool M; Evers R
    Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
    Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
    Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
    Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI
    Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium butyrate-induced expression of lung resistance-related gene in human myeloid leukemia K562 cells].
    Li N; Qian XH; Yao YM; Wang ZY
    Ai Zheng; 2003 Aug; 22(8):821-5. PubMed ID: 12917027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
    Sumizawa T; Chen ZS; Chuman Y; Seto K; Furukawa T; Haraguchi M; Tani A; Shudo N; Akiyama SI
    Mol Pharmacol; 1997 Mar; 51(3):399-405. PubMed ID: 9058594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution.
    Cheng SH; Lam W; Lee AS; Fung KP; Wu RS; Fong WF
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):134-42. PubMed ID: 10764626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
    Vanhoefer U; Cao S; Minderman H; Tóth K; Scheper RJ; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Feb; 2(2):369-77. PubMed ID: 9816180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
    Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
    Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2).
    Kawabe T; Chen ZS; Wada M; Uchiumi T; Ono M; Akiyama S; Kuwano M
    FEBS Lett; 1999 Aug; 456(2):327-31. PubMed ID: 10456333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
    Evers R; Kool M; van Deemter L; Janssen H; Calafat J; Oomen LC; Paulusma CC; Oude Elferink RP; Baas F; Schinkel AH; Borst P
    J Clin Invest; 1998 Apr; 101(7):1310-9. PubMed ID: 9525973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2.
    Suzuki H; Sugiyama Y
    Semin Liver Dis; 1998; 18(4):359-76. PubMed ID: 9875554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
    Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ
    Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.